SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SK Chemicals Co Ltd (006120) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3436
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance resins which include skybon, chemicals for electronics, skyviva, skynova, skyflex, SK compound, and ecotran. The company offers biomaterials such as ecoprime and ecoplan. It also provides new synthetic and botanical drugs, and vaccines. The company has operations in South Korea, the US, China, Japan, Korea, Germany and Singapore. SK Chemicals is headquartered in Gyeonggi-do, South Korea.

SK Chemicals Co Ltd (006120) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 10
SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811 11
SK Chemicals and International Vaccine Institute Enters into Agreement 12
SK Chemicals Enters Into Co-Development Agreement With DNA Link 13
Licensing Agreements 14
Sanofi Pasteur Enters into Licensing Agreement with SK Chemicals 14
Hikma Pharma Enters into Licensing Agreement with SK Chemicals 15
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 16
SK Chemicals Co Ltd – Key Competitors 17
SK Chemicals Co Ltd – Key Employees 18
SK Chemicals Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Product News 21
01/09/2017: AFSTYLA, for Haemophilia A, Receives European Commission Approval 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 10
SK Biopharma Enters Into Co-Development Agreement With SK Chemicals For YKP-10811 11
SK Chemicals and International Vaccine Institute Enters into Agreement 12
SK Chemicals Enters Into Co-Development Agreement With DNA Link 13
Sanofi Pasteur Enters into Licensing Agreement with SK Chemicals 14
Hikma Pharma Enters into Licensing Agreement with SK Chemicals 15
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 16
SK Chemicals Co Ltd, Key Competitors 17
SK Chemicals Co Ltd, Key Employees 18
SK Chemicals Co Ltd, Other Locations 19
SK Chemicals Co Ltd, Subsidiaries 19
SK Chemicals Co Ltd, Joint Venture 20

List of Figures
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SK Chemicals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SK Chemicals Co Ltd (006120):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tilaknagar Industries Ltd:企業の戦略・SWOT・財務分析
    Tilaknagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Grasim Industries Limited:企業の戦略・SWOT・財務情報
    Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Advanced Marker Discovery SL-医療機器分野:企業M&A・提携分析
    Summary Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company offers test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It provides diagnostic tools that support the physician’s decisions about patient manage …
  • Newfoundland Power Inc.:企業の戦略的SWOT分析
    Newfoundland Power Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務情報
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oneok Inc (OKE):石油・ガス:M&Aディール及び事業提携情報
    Summary Oneok Inc (ONEOK) is an oil and gas company that processes, gathers, storages and transports natural gas. The company's products include natural gas and natural gas liquids. It offers services such as natural gas, natural gas pipelines, and natural gas liquids gathering, processing, marketin …
  • Frontline Ltd (FRO):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontline Ltd (Frontline) is a shipping company. It transports crude oil and its related refined petroleum products. The company owns and operates very large crude carriers (VLCCs), Suezmax tankers, and Aframax/LR2 tankers. Its vessels operate in the spot and time charter markets. Frontline’ …
  • Ornua Co-operative Ltd:企業の戦略・SWOT・財務分析
    Ornua Co-operative Ltd - Strategy, SWOT and Corporate Finance Report Summary Ornua Co-operative Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Construcciones y Auxiliar de Ferrocarriles SA:戦略・SWOT・企業財務分析
    Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report Summary Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Kesoram Industries Ltd:企業の戦略・SWOT・財務情報
    Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Reliance Power Ltd (RPOWER):電力:M&Aディール及び事業提携情報
    Summary Reliance Power Ltd (RPower), formerly Reliance Energy Generation Private Limited, is a power generation and coal resources company. It develops, constructs, and operates power projects and coal mines. The company produces electricity from various sources of electricity including coal, solar …
  • Dart Container Corporation:企業の戦略・SWOT・財務分析
    Dart Container Corporation - Strategy, SWOT and Corporate Finance Report Summary Dart Container Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Saudi Cable Company (2110):企業の財務・戦略的SWOT分析
    Saudi Cable Company (2110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TTEC Holdings Inc.:企業の戦略・SWOT・財務情報
    TTEC Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary TTEC Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • C.H. Robinson Worldwide, Inc.:企業の戦略・SWOT・財務情報
    C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Turkcell Iletisim Hizmetleri AS (TCELL):企業の財務・戦略的SWOT分析
    Turkcell Iletisim Hizmetleri AS (TCELL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dynapac Co., Ltd.:企業の戦略・SWOT・財務情報
    Dynapac Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynapac Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Autolus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses chimeric antigen receptors (CARs) or T-cell receptors (TCRs) t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆